Lotus Tissue Repair Closes $26M Series A
Lotus Tissue Repair Inc. has raised $26 million in a Series A round led by Third Rock Ventures. The company is developing technology to be used in the treatment of dystrophic epidermolysis bullosa, “an orphan disease that causes devastating skin blisters, morbidity and early mortality,” the company said in a release. The infusion of cash will be used to continue development.
30 June 2011•4 mins read
